ALLMedicine™ Glucose Tolerance Testing Center
Research & Reviews 252 results
https://doi.org/10.1515/jpm-2021-0581
Journal of Perinatal Medicine; Hillier TA, Pedula KL et. al.
May 10th, 2022 - Gestational diabetes (GDM) screening at 24-28 weeks' gestation reduces risk of adverse maternal and perinatal outcomes. While experts recommend first-trimester screening for high-risk patients, including those with obesity, data supporting this re...
https://doi.org/10.1210/clinem/dgac285
The Journal of Clinical Endocrinology and Metabolism; Baidal DA, Warnock M et. al.
May 8th, 2022 - Decreased first-phase insulin response (FPIR) during intravenous glucose tolerance testing (IVGTT) is an early indicator of β-cell dysfunction and predictor of type 1 diabetes (T1D). Assess whether oral glucose tolerance test (OGTT) measures could...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977731
Diabetes & Vascular Disease Research; Wanger L, Gar C et. al.
Apr 1st, 2022 - Skeletal muscle contributes significantly to insulin sensitivity in humans. However, which non-invasive measurement best reflects this contribution remains unknown. Consequently, this paper compares morphologic and functional measurements. We cond...
https://doi.org/10.1016/j.numecd.2022.02.013
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Naeem M, Schipf S et. al.
Mar 15th, 2022 - While there is evidence that iron overload disorders are associated with type 2 diabetes, the relationship between hepatic iron overload and prediabetes remains unclear. We aimed to investigate the association between hepatic iron overload, as ass...
https://doi.org/10.1016/j.diabres.2022.109815
Diabetes Research and Clinical Practice; Khalafi M, Ravasi AA et. al.
Mar 11th, 2022 - We performed a systematic review and meta-analysis to investigate the effects of high-intensity interval training (HIIT) on postprandial glucose (PPG) and insulin (PPI) versus non-exercise control and moderate-intensity continuous training (MICT) ...
Drugs 8 results see all →
Clinicaltrials.gov 16 results
https://clinicaltrials.gov/ct2/show/NCT05058690
Mar 8th, 2022 - This multicentre prospective study will evaluate the ability of the FatHealth technology to correctly identify individuals with pre-diabetes and diabetes, validating the technology against the current gold-standard diagnostic method, oral glucose ...
https://clinicaltrials.gov/ct2/show/NCT03025984
Nov 3rd, 2021 - As a part of routine care, pregnant women without known diabetes undergo screening and testing for gestational diabetes either with a two-hour glucose tolerance testing or a one-hour glucose challenge test followed by a three-hour glucose toleranc...
https://clinicaltrials.gov/ct2/show/NCT03761290
May 27th, 2021 - Pseudohypoparathyroidism type 1A (PHP1A) is a rare, genetic disorder caused by impaired stimulatory G-protein signaling due to heterozygous mutations in the gene, GNAS. The most severe form of the disease, PHP1A occurs when a GNAS mutation is inhe...
https://clinicaltrials.gov/ct2/show/NCT04190199
Dec 9th, 2019 - Women with a history of gestational diabetes mellitus (GDM) or post-GDM are at high risk of developing type 2 diabetes (T2DM). This is important in the present context because T2DM has reached epidemic proportions. In Malaysia, the prevalence of T...
https://clinicaltrials.gov/ct2/show/NCT00867126
Nov 26th, 2018 - OBJECTIVES: Primary To describe changes in markers of insulin resistance, including serum adiponectin levels, standard glucose tolerance testing, and fasting serum glucose and insulin levels, in patients with previously treated metastatic adenocar...
News 22 results
https://www.medpagetoday.com/neurology/sleepdisorders/97048
Feb 7th, 2022 - More sleep was linked with fewer calories consumed, a single-center randomized clinical trial showed. Compared with controls, young adults who were overweight and habitually slept less than 6.5 hours a night slept an extra 1.2 hours on average aft...
https://www.mdedge.com/internalmedicine/article/218148/obstetrics/gestational-diabetes-early-postpartum-glucose-testing?channel=39313
Kari Oakes
Mar 1st, 2020 - GRAPEVINE, TEX. – Early postpartum glucose tolerance testing for women with gestational diabetes resulted in a 99% adherence rate, with similar sensitivity and specificity as the currently recommended 4- to 12-week postpartum testing schedule.
https://www.mdedge.com/pediatrics/article/202556/diabetes/teplizumab-delays-onset-type-1-diabetes
Bianca Nogrady
Jun 9th, 2019 - The monoclonal antibody teplizumab may delay the onset of type 1 diabetes in individuals at high risk, according to research presented at the annual scientific sessions of the American Diabetes Association. In this study, 76 first-degree relatives.
https://www.medscape.com/viewarticle/911202
Apr 2nd, 2019 - Metformin continues to reduce the likelihood of developing type 2 diabetes among those at high risk for it over 15 years, particularly among those with higher baseline glycemia and women with a history of gestational diabetes mellitus (GDM). Findi...
https://www.staging.medscape.com/viewarticle/911202
Apr 2nd, 2019 - Metformin continues to reduce the likelihood of developing type 2 diabetes among those at high risk for it over 15 years, particularly among those with higher baseline glycemia and women with a history of gestational diabetes mellitus (GDM). Findi...